Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28628160 | 0.90 | CHRM5 (0.37) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL28918485 | 0.86 | CHRM5 (0.35) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL930621 | 0.82 | MEN1 (0.34) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL9540412 | 0.82 | MEN1 (0.34) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL9765922 | 0.81 | OPRD1 (0.33) | OPRD1 | |
| SCHEMBL3387239 | 0.80 | CHRM5 (0.32) | SIGMAR1CHRM5CHRM3 | |
| SCHEMBL28204363 | 0.78 | GNAI3 (0.33) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL3389599 | 0.77 | CHRM5 (0.35) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL1303959 | 0.75 | ADH1B (0.37) | SIGMAR1MEN1KMT2ACHRM5CHRM3 | |
| SCHEMBL1303957 | 0.75 | CHRM5 (0.34) | SIGMAR1MEN1KMT2ACHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11292768-B2 | Process for manufacturing chain-extended hydroxyethylethyleneamines, ethyleneamines, or mixtures thereof | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-04-05 | — | — | US | claimed |
| EP-3596039-B1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | NOURYON CHEMICALS INT BV (NL) | 2021-05-05 | — | — | EP | claimed |
| US-20200131136-A1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-04-30 | — | — | US | claimed |
| WO-2018166938-A1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2018-09-20 | — | — | WO | claimed |
| US-20160304662-A1 | PROCESS FOR FORMING AN ORGANIC POLYMER IN A REACTION OF A POLYENE, AN EPOXY RESIN AND A MIXTURE OF THIOL AND AMINE CURING AGENTS | DOW GLOBAL TECHNOLOGIES LLC | 2016-10-20 | — | — | US | claimed |
| US-11390741-B2 | Epoxy resin compositions containing an internal mold release agent | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-07-19 | — | — | US | disclosed |
| CN-108602788-B | Process for preparing higher ethyleneamines and ethyleneamine derivatives | 阿克苏诺贝尔化学品国际有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-11292768-B2 | Process for manufacturing chain-extended hydroxyethylethyleneamines, ethyleneamines, or mixtures thereof | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2022-04-05 | — | — | US | disclosed |
| US-20220002536-A1 | EPOXY RESIN COMPOSITIONS CONTAINING AN INTERNAL MOLD RELEASE AGENT | DOW GLOBAL TECHNOLOGIES LLC | 2022-01-06 | — | — | US | disclosed |
| EP-3596039-B1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | NOURYON CHEMICALS INT BV (NL) | 2021-05-05 | — | — | EP | disclosed |
| EP-3592796-B1 | STABLE EPOXY/INTERNAL MOLD RELEASE AGENT BLENDS FOR THE MANUFACTURE OF COMPOSITE ARTICLES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-21 | — | — | EP | disclosed |
| US-20200181361-A1 | STABLE EPOXY/INTERNAL MOLD RELEASE AGENT BLENDS FOR THE MANUFACTURE OF COMPOSITE ARTICLES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-06-11 | — | — | US | disclosed |
| US-20170369635-A1 | RAPID-SET EPOXY RESIN SYSTEMS AND PROCESS OF COATING PIPELINES USING THE EPOXY RESIN SYSTEM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-12-28 | — | — | US | disclosed |
| US-20170029673-A1 | POLYURETHANE-ACRYLATE EPOXY ADHESIVE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-02-02 | — | — | US | disclosed |
| US-20160304662-A1 | PROCESS FOR FORMING AN ORGANIC POLYMER IN A REACTION OF A POLYENE, AN EPOXY RESIN AND A MIXTURE OF THIOL AND AMINE CURING AGENTS | DOW GLOBAL TECHNOLOGIES LLC | 2016-10-20 | — | — | US | disclosed |
| EP-0629194-A1 | CATALYTIC REFORMING OF CYCLIC ALKYLENEAMINES | THE DOW CHEMICAL COMPANY (US) | 1994-12-21 | — | — | EP | disclosed |
| EP-0535033-A4 | PROCESS OF PREPARING LINEARLY-EXTENDED POLYALKYLENEPOLYAMINES EMPLOYING METAL SILICATE CATALYSTS | DOW CHEMICAL CO (US) | 1994-05-25 | — | — | EP | disclosed |
| WO-1993018017-A1 | CATALYTIC REFORMING OF CYCLIC ALKYLENEAMINES | THE DOW CHEMICAL COMPANY (US) | 1993-09-16 | — | — | WO | disclosed |
| EP-0535033-A1 | Process for preparing a linearly-extended polyalkylenepolyamine | THE DOW CHEMICAL COMPANY (US) | 1993-04-07 | — | — | EP | disclosed |
| WO-1992000271-A1 | PROCESS OF PREPARING LINEARLY-EXTENDED POLYALKYLENEPOLYAMINES EMPLOYING METAL SILICATE CATALYSTS | THE DOW CHEMICAL COMPANY (US) | 1992-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11292768-B2 | Process for manufacturing chain-extended hydroxyethylethyleneamines, ethyleneamines, or mixtures thereof | HNMT, PNMT, HRH2 | SIGMAR1 224/4885MEN1 2374/4885KMT2A 446/4885 |
| US-20200131136-A1 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | HNMT, PNMT, HRH2 | SIGMAR1 224/4885MEN1 2374/4885KMT2A 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.